Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 4Cohance Lifesciences
02 2Strides Pharma Science
03 1Mankind Pharma
04 1ABRAXIS PHARM
05 7Abbott Laboratories
06 11Actavis Inc
07 2Amneal Pharmaceuticals
08 1Amphastar Pharmaceuticals
09 3Apotex Fermentation Inc.
10 1Aurobindo Pharma Limited
11 4Avet Pharmaceuticals
12 7Azurity Pharma
13 1BEDFORD LABS
14 2Caplin Point Laboratories Limited
15 3Chartwell Pharmaceuticals llc
16 2Exela Pharma Sciences, LLC.
17 4Farbe Firma
18 1Fresenius Kabi USA
19 1GD Searle LLC
20 1GLAND PHARMA LIMITED
21 3Glenmark Pharmaceuticals
22 7Hospira, Inc.
23 3IVAX Pharmaceuticals Inc
24 2Luitpold Pharmaceuticals, Inc.
25 2MARSAM PHARMS LLC
26 4MT ADAMS
27 2Micro Labs Limited
28 2Mutual Pharmaceutical Company, Inc.
29 2Nephron Pharmaceuticals Corporation
30 9Pfizer Inc
31 1Pharmascience Inc.
32 4Pliva Hrvatska
33 1Pluviaendo
34 1Quad Pharma
35 8Rising Pharmaceuticals Inc
36 2SMITH & NEPHEW INC
37 1Smith & Kenner Pharmaceuticals
38 1Solo Pak
39 4Somerset Pharmaceuticals Inc
40 5Sun Pharmaceutical Industries Limited
41 10Viatris
42 2Warner Chilcott Company, LLC
43 3Zydus Lifesciences
44 1Zydus Pharmaceuticals
01 13CAPSULE, EXTENDED RELEASE;ORAL
02 1Capsule
03 3Extended-Release Tablet
04 4Film Coated Tablet
05 21INJECTABLE;INJECTION
06 1Injectable Solution
07 1Injectable; Injection
08 4Injection
09 1Modified Release Capsule
10 18SOLUTION;INTRAVENOUS
11 1SRC
12 4Sustain Release Capsule
13 4TAB
14 1TABLET (EXTENDED-RELEASE)
15 26TABLET, EXTENDED RELEASE;ORAL
16 35TABLET;ORAL
17 1Tablet
01 1Allowed
02 7Authorized
03 66DISCN
04 1Deregistered
05 1Generic
06 4Originator
07 1Prescription
08 47RX
09 11Blank
01 5CALAN
02 3CALAN SR
03 2COVERA-HS
04 4ISOPTIN
05 2Manidon
06 1Manidon Hta
07 1Manidon Hta Gradual-Release Tablets
08 2Manidon Retard
09 1PMS-VERAPAMIL SR
10 4Tarka
11 2Tarka 180/2
12 2Tarka 240/4
13 1VERAPAMIL HCL
14 92VERAPAMIL HYDROCHLORIDE
15 4VERELAN
16 3VERELAN PM
17 10Blank
01 1Canada
02 9India
03 5South Africa
04 7Spain
05 1Sweden
06 1Switzerland
07 1Turkey
08 114USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Capsule
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 120MG
Packaging :
Approval Date : 1999-05-25
Application Number : 75072
Regulatory Info : RX
Registration Country : USA
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 2022-06-15
Application Number : 214653
Regulatory Info : RX
Registration Country : USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Capsule
Dosage Strength : 180MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Capsule
Dosage Strength : 240MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Capsule
Dosage Strength : 360MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 240MG
Packaging :
Approval Date : 1999-05-25
Application Number : 75072
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/2ML (2.5MG/ML)
Packaging :
Approval Date : 1984-03-30
Application Number : 18925
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VERAPAMIL HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/4ML (2.5MG/ML)
Packaging :
Approval Date : 2018-04-05
Application Number : 18925
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 1984-03-30
Application Number : 19038
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1984-09-10
Application Number : 18817
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : TABLET;ORAL
Dosage Strength : 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1984-09-10
Application Number : 18817
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-02-23
Application Number : 18817
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN
Dosage Form : TABLET;ORAL
Dosage Strength : 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-02-23
Application Number : 18817
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN SR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1986-12-16
Application Number : 19152
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALAN SR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1989-12-15
Application Number : 19152
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISOPTIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 18485
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISOPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-03-08
Application Number : 18593
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISOPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-03-08
Application Number : 18593
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISOPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1987-11-23
Application Number : 18593
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
